ICICIGI - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.0
| Stock Code | ICICIGI | Market Cap | 90,821 Cr. | Current Price | 1,829 ₹ | High / Low | 2,075 ₹ |
| Stock P/E | 33.2 | Book Value | 331 ₹ | Dividend Yield | 0.68 % | ROCE | 24.9 % |
| ROE | 18.8 % | Face Value | 10.0 ₹ | DMA 50 | 1,910 ₹ | DMA 200 | 1,914 ₹ |
| Chg in FII Hold | -0.69 % | Chg in DII Hold | 0.84 % | PAT Qtr | 659 Cr. | PAT Prev Qtr | 820 Cr. |
| RSI | 37.9 | MACD | -36.6 | Volume | 2,65,622 | Avg Vol 1Wk | 9,76,615 |
| Low price | 1,613 ₹ | High price | 2,075 ₹ | PEG Ratio | 1.31 | Debt to equity | 0.00 |
| 52w Index | 46.8 % | Qtr Profit Var | -9.06 % | EPS | 55.0 ₹ | Industry PE | 33.2 |
💹 Core Financials: ICICI Lombard General Insurance (ICICIGI) demonstrates solid profitability with ROE at 18.8% and ROCE at 24.9%, reflecting efficient capital utilization. Debt-to-equity ratio of 0.00 indicates a debt-free balance sheet, ensuring financial stability. Quarterly PAT declined from ₹820 Cr. to ₹659 Cr., showing a contraction of -9.06%, which highlights earnings pressure. Dividend yield of 0.68% provides modest income. EPS at ₹55.0 reflects consistent earnings power.
📊 Valuation Indicators: Current P/E of 33.2 is in line with the industry average of 33.2, suggesting fair valuation. Book value of ₹331 against CMP of ₹1,829 implies a P/B ratio of ~5.5, which is relatively high. PEG ratio of 1.31 indicates valuations are moderately stretched relative to growth prospects. Intrinsic value appears close to CMP, offering balanced risk-reward.
🏢 Business Model & Competitive Advantage: ICICIGI operates in general insurance, offering motor, health, property, and liability insurance. Its competitive advantage lies in strong brand equity, diversified product portfolio, and leadership in motor and health insurance segments. However, profitability remains sensitive to claim ratios, regulatory changes, and competitive pricing pressures.
💰 Entry Zone Recommendation: Considering DMA 50 at ₹1,910 and DMA 200 at ₹1,914, the stock is trading below averages, showing weakness. A favorable entry zone would be ₹1,700–₹1,780 during corrections. Current levels are fairly valued but not deeply undervalued.
📈 Long-Term Holding Guidance: ICICIGI remains a fundamentally strong company with consistent earnings, debt-free status, and strong brand presence. Long-term investors can hold confidently, while new investors should accumulate gradually on dips for better risk-reward balance.
Positive
- ROE (18.8%) and ROCE (24.9%) reflect strong efficiency.
- Debt-free balance sheet ensures financial stability.
- Strong brand equity and diversified insurance portfolio.
- Increase in DII holdings (+0.84%) reflects domestic institutional support.
Limitation
- Quarterly PAT declined by -9.06%, showing earnings pressure.
- P/B ratio (~5.5) indicates expensive valuation relative to book value.
- Dividend yield of 0.68% offers modest income.
- Stock trading below DMA 50 and DMA 200 shows technical weakness.
Company Negative News
- Decline in FII holdings (-0.69%) signals reduced foreign investor confidence.
- MACD at -36.6 indicates bearish technical momentum.
Company Positive News
- Increase in DII holdings (+0.84%) reflects strong domestic institutional support.
- Strong demand outlook in health and motor insurance segments.
- Debt-free balance sheet supports resilience.
Industry
- General insurance industry benefits from rising demand in health and motor insurance.
- Industry P/E at 33.2 suggests peers trade at similar valuations.
- Competition from HDFC Ergo, Bajaj Allianz, and SBI General keeps pricing pressure high.
Conclusion
⚖️ ICICIGI is a fundamentally strong company with consistent earnings, debt-free status, and strong brand presence. Valuations are fair compared to industry peers, though profitability has shown recent pressure. Long-term investors can hold confidently, while new investors should look for entry around ₹1,700–₹1,780 to optimize returns.
Would you like me to also prepare a peer comparison HTML snippet against HDFC Ergo and Bajaj Allianz to highlight relative strengths and weaknesses in the insurance sector?